Alnylam Pharmaceuticals | Zinsertrag

Aktienkurs
333.76
Täglich Wechseln
19.36 6.16%
Monatlich
-6.12%
Jährlich
33.50%
Q1 Prognose
304.65




Zinsertrag Veränderung Datum
Acadia Pharmaceuticals USD 7.24M 658K 2025-06
Agios Pharmaceuticals USD 13.37M 1.14M 2025-09
Alnylam Pharmaceuticals USD 28.68M 1.19M 2025-09
Arrowhead Research USD 9.05M 1.97M 2025-09
BioCryst Pharmaceuticals USD -0.13 3.59M 2024-12
BioMarin Pharmaceutical USD 18.83M 186K 2025-06
Incyte USD 30.75M 3.97M 2025-12
Ionis Pharmaceuticals USD -0.66 0.29 2024-12
Moderna USD 73M 8M 2025-09
Regeneron Pharmaceuticals USD 175.1M 300K 2025-09
Sanofi EUR 114M 38M 2025-09
Sarepta Therapeutics USD 7.14M 3.05M 2025-06
Takeda JPY 87.87B 43.48B 2025-12
Tectonic Therapeutic USD 1.74M 217K 2024-12
Ultragenyx Pharmaceutical USD 5.86M 69K 2025-09
Vertex Pharmaceuticals USD 125.7M 3.3M 2025-09
Xencor USD 7.25M 290K 2025-06


Alnylam Pharmaceuticals Zinsertrag - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.